EE9900543A - Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool - Google Patents
Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsoolInfo
- Publication number
- EE9900543A EE9900543A EEP199900543A EEP9900543A EE9900543A EE 9900543 A EE9900543 A EE 9900543A EE P199900543 A EEP199900543 A EE P199900543A EE P9900543 A EEP9900543 A EE P9900543A EE 9900543 A EE9900543 A EE 9900543A
- Authority
- EE
- Estonia
- Prior art keywords
- bioavailability
- protease inhibitor
- hiv protease
- oral absorption
- sulphate salt
- Prior art date
Links
- 229940122440 HIV protease inhibitor Drugs 0.000 title 1
- 238000010521 absorption reaction Methods 0.000 title 1
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
| PCT/US1998/010633 WO1998054178A1 (en) | 1997-05-29 | 1998-05-26 | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900543A true EE9900543A (et) | 2000-06-15 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900543A EE9900543A (et) | 1997-05-29 | 1998-05-26 | Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (et) |
| JP (1) | JP3267632B2 (et) |
| KR (1) | KR20010013042A (et) |
| CN (1) | CN1257497A (et) |
| AU (1) | AU730245B2 (et) |
| BG (1) | BG103923A (et) |
| BR (1) | BR9809498A (et) |
| CA (1) | CA2291086A1 (et) |
| EA (1) | EA199901095A1 (et) |
| EE (1) | EE9900543A (et) |
| HR (1) | HRP980283A2 (et) |
| HU (1) | HUP0004621A3 (et) |
| ID (1) | ID23858A (et) |
| IL (1) | IL132779A0 (et) |
| IS (1) | IS5240A (et) |
| NO (1) | NO995822L (et) |
| PE (1) | PE75099A1 (et) |
| PL (1) | PL336847A1 (et) |
| SK (1) | SK163299A3 (et) |
| TR (1) | TR199902816T2 (et) |
| TW (1) | TW438799B (et) |
| WO (1) | WO1998054178A1 (et) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU777824B2 (en) * | 1999-11-24 | 2004-11-04 | Merck Sharp & Dohme Corp. | Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1- piperazinepentanamides as HIV protease inhibitors |
| US20020082421A1 (en) * | 2000-09-14 | 2002-06-27 | Abdel-Magid Ahmed F. | Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3000564B2 (ja) * | 1993-12-15 | 2000-01-17 | メルク エンド カンパニー インコーポレーテッド | Ｈｉｖプロテアーゼ阻害剤 |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/zh active
- 1998-05-26 CN CN98805372A patent/CN1257497A/zh active Pending
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 ID IDW991462A patent/ID23858A/id unknown
- 1998-05-26 IL IL13277998A patent/IL132779A0/xx unknown
- 1998-05-26 EA EA199901095A patent/EA199901095A1/ru unknown
- 1998-05-26 SK SK1632-99A patent/SK163299A3/sk unknown
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/pt not_active Application Discontinuation
- 1998-05-26 EE EEP199900543A patent/EE9900543A/et unknown
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/ko not_active Withdrawn
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/xx unknown
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/hu unknown
- 1998-05-26 PL PL98336847A patent/PL336847A1/xx unknown
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Ceased
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-26 JP JP50079999A patent/JP3267632B2/ja not_active Expired - Fee Related
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/hr not_active Application Discontinuation
- 1998-05-28 PE PE1998000432A patent/PE75099A1/es not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/is unknown
- 1999-11-24 BG BG103923A patent/BG103923A/xx unknown
- 1999-11-26 NO NO995822A patent/NO995822L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0004621A2 (hu) | 2002-03-28 |
| HUP0004621A3 (en) | 2002-04-29 |
| EA199901095A1 (ru) | 2000-08-28 |
| BG103923A (en) | 2000-06-30 |
| NO995822D0 (no) | 1999-11-26 |
| AU730245B2 (en) | 2001-03-01 |
| IS5240A (is) | 1999-11-09 |
| TR199902816T2 (xx) | 2000-02-21 |
| JP2000513747A (ja) | 2000-10-17 |
| JP3267632B2 (ja) | 2002-03-18 |
| EP0986554A1 (en) | 2000-03-22 |
| AU7595998A (en) | 1998-12-30 |
| PE75099A1 (es) | 1999-08-11 |
| PL336847A1 (en) | 2000-07-17 |
| WO1998054178A1 (en) | 1998-12-03 |
| KR20010013042A (ko) | 2001-02-26 |
| SK163299A3 (en) | 2000-07-11 |
| ID23858A (id) | 2000-05-25 |
| HRP980283A2 (en) | 1999-08-31 |
| NO995822L (no) | 2000-01-28 |
| CN1257497A (zh) | 2000-06-21 |
| TW438799B (en) | 2001-06-07 |
| CA2291086A1 (en) | 1998-12-03 |
| IL132779A0 (en) | 2001-03-19 |
| BR9809498A (pt) | 2000-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000725A (et) | Uued 3-arüülpropaanhappe derivaadid ja nende analoogid | |
| NL300952I2 (nl) | Peramivir en farmaceutisch aanvaardbare zouten daarvan | |
| DE69928195D1 (de) | Komplettierung von Untrerdruck-Bohrlöchern | |
| EE200100258A (et) | Antraniilhappe amiidid ja nende kasutamine ravimitena | |
| DE69823016D1 (de) | Wässrige lösungen von salicylsaure derivaten | |
| CY2012029I2 (el) | Nεα μορφη της 5-ομεπραζολης | |
| EE200100022A (et) | Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon | |
| FI953968A7 (fi) | Antraniiliset happojohdannaiset | |
| EE04434B1 (et) | HIV proteaasi inhibiitori bisulfaatsool | |
| DE69502726D1 (de) | Hestellung von aniontensidgranulaten | |
| MA26668A1 (fr) | ACTIVATEURS DE hPPARy ET hPPARa | |
| EE200100632A (et) | Amlodipiini ja atorvastatiini ühine sool | |
| FI970317A7 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
| EP1009377A4 (en) | MEDICAL USE OF PYRUVATES | |
| EE200200146A (et) | Loteprednooli ja antihistamiinsete ainete uudne kombinatsioon | |
| EE200000506A (et) | Meta-asatsüklilised aminobensoehappeühendid ja nende derivaadid integriini antagonistidena | |
| FI971711L (fi) | Levobupivakaiinin ja sen analogien kiteyttäminen | |
| DE69508812D1 (de) | Sulfoniumsalz und chemisch verstärkte Positivresistzusammensetzungen | |
| EE200100051A (et) | Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon | |
| ATE254929T1 (de) | Oralverabreichbare lösung von prucaloprid | |
| FI956116A7 (fi) | N-fosfonometyyliglysiinin ja sen suolojen valmistus | |
| EE9900543A (et) | Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool | |
| EE200100017A (et) | N-tert-butüülhüdroksüülamiini uued soolad | |
| DE59807008D1 (de) | Aluminiumsalze von alkylhydroxymethylphosphinsäuren | |
| DE69400693D1 (de) | Minderung von NOx-Emissionen |